Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Marcus V.B. Malachias"'
Autor:
Magnus O. Wijkman, Marcus V.B. Malachias, Brian L. Claggett, Susan Cheng, Kunihiro Matsushita, Amil M. Shah, Pardeep S. Jhund, Josef Coresh, Scott D. Solomon, Orly Vardeny
Publikováno v:
The Journal of Clinical Hypertension, Vol 23, Iss 10, Pp 1887-1896 (2021)
Abstract More stringent blood pressure (BP) goals have led to greater prevalence of apparent resistant hypertension (ARH), yet the long‐term prognostic impact of ARH diagnosed according to these goals in the general population remains unknown. We a
Externí odkaz:
https://doaj.org/article/b7ec8b8f90a3457a905ce74c16c91519
Autor:
Amil M. Shah, Brian Claggett, Josef Coresh, Magnus Wijkman, Pardeep S. Jhund, Kunihiro Matsushita, Marcus V.B. Malachias, Orly Vardeny, Scott D. Solomon, Susan Cheng
Publikováno v:
The Journal of Clinical Hypertension
More stringent blood pressure (BP) goals have led to greater prevalence of apparent resistant hypertension (ARH), yet the long-term prognostic impact of ARH diagnosed according to these goals in the general population remains unknown. We assessed the
Autor:
Magnus O. Wijkman, Brian L. Claggett, Marcus V.B. Malachias, Muthiah Vaduganathan, Christie M. Ballantyne, Dalane W. Kitzman, Thomas Mosley, Kunihiro Matsushita, Scott D. Solomon, Marc A. Pfeffer
Publikováno v:
Diabetes research and clinical practice. 194
In this community-based cohort of 5861 individuals followed for median 7.2 years, the discriminatory ability of NT-proBNP alone in predicting mortality was similar to that of multiple conventional markers of risk in people without diabetes. In people
Autor:
Nishi Chaturvedi, Dick de Zeeuw, Hans-Henrik Parving, Scott D. Solomon, Marcus V.B. Malachias, Brian Claggett, Steven M. Haffner, Pardeep S. Jhund, Magnus Wijkman, John J.V. McMurray, Patrick Brunel, Marc A. Pfeffer, Rhonda Bentley-Lewis, Akshay S. Desai, Margaret F. Prescott
Publikováno v:
Diabetes. 69
We assessed the relative contributions of N-terminal pro-B-type natriuretic peptide (NTBNP) and high sensitivity cardiac troponin (hsTnT) to the prediction of death and cardiovascular (CV) events in 5597 (with complete data) of 8561 patients with typ